Aditxt, Inc.

ADTX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Assets
Cash & Equivalents $3.2M $833.0K $97.1K $2.8M $7.9M $10.5M $4.1K
Accounts Receivable — $43.4K $408.3K $528.0K $89.8K — —
Inventory $5.8K $11.2K $745.5K $950.1K — — —
Total Current Assets $3.8M $2.0M $6.9M $4.7M $9.4M $11.0M $4.1K
Property, Plant & Equipment $880.2K $1.5M $1.9M $2.3M $2.3M $798.9K —
Goodwill — — — — — — —
Intangible Assets (Excl. Goodwill) $2.8K $6.1K $9.4K $107.0K $321.0K — —
Total Assets $16.5M $32.1M $44.6M $10.7M $16.7M $13.1M $123.5K
Liabilities
Accounts Payable $7.3M $10.2M $7.5M $2.0M $1.6M $241.6K $1.8M
Total Current Liabilities $12.2M $23.4M $25.9M $3.6M $3.6M $1.2M $3.0M
Long-Term Debt — — — — — — —
Total Liabilities $12.6M $23.9M $28.5M $5.5M $6.5M $2.1M $3.0M
Stockholders' Equity
Retained Earnings $-209.8M $-168.1M $-127.7M $-95.0M $-67.4M $-20.9M $-11.7M
Total Stockholders' Equity $5.6M $1.7M $16.1M $5.2M $10.2M $11.0M $-2.9M